Role and treatment advances of renin-angiotensin system in children with vesicourethral dysfunction

References:

1 Passos-Silva DG,Brandan E,Santos RA.Angiotensins as therapeutic targets beyond heart disease[J].Trends Pharmacol Sci,2015,36(5):310-320.DOI:10.1016/j.tips.2015.03.001.
2 Santos RA,Brosnihan KB,Chappell MC,et al.Converting enzyme activity and angiotensin metabolism in the dog brainstem[J].Hypertension,1988,11(2 Pt 2):153-157.DOI:10.1161/01.hyp.11.2_pt_2.i153.
3 Tipnis SR,Hooper NM,Hyde R,et al.A human homolog of angiotensin-converting enzyme.Cloning and functional expression as a captopril-insensitive carboxypeptidase[J].J Biol Chem,2000,275(43):33238-33243.DOI:10.1074/jbc.M002615200.
4 Santos RA,Simoes E Silva AC,Maric C,et al.Angiotensin-(1-7) is an endogenous ligand for the g protein-coupled receptor mas[J].Proc Natl Acad Sci USA,2003,100(14):8258-8263.DOI:10.1073/pnas.1432869100.
5 Britto RR,Santos RA,Fagundes-Moura CR,et al.Role of angiotensin-(1-7) in the modulation of the baroreflex in renovascular hypertensive rats[J].Hypertension,1997,30(3 Pt 2):549-556.DOI:10.1161/01.hyp.30.3.549.
6 Ebermann L,Spillmann F,Sidiropoulos M,et al.The angiotensin-(1-7) receptor agonist ave0991 is cardioprotective in diabetic rats[J].Eur J Pharmacol,2008,590(1-3):276-280.DOI:10.1016/j.ejphar.2008.05.024.
7 Santos RAS,Sampaio WO,Alzamora AC,et al.The ace2/angiotensin-(1-7)/mas axis of the renin-angiotensin system:Focus on angiotensin-(1-7)[J].Physiol Rev,2018,98(1):505-553.DOI:10.1152/physrev.00023.2016.
8 Patel VB,Lezutekong JN,Chen X,et al.Recombinant human ace2 and the angiotensin 1-7 axis as potential new therapies for heart failure[J].Can J Cardiol,2017,33(7):943-946.DOI:10.1016/j.cjca.2016.12.012.
9 Sukumaran V,Veeraveedu PT,Gurusamy N,et al.Telmisartan acts through the modulation of ace-2/ang 1-7/mas receptor in rats with dilated cardiomyopathy induced by experimental autoimmune myocarditis[J].Life Sci,2012,90(7-8):289-300.DOI:10.1016/j.lfs.2011.11.018.
10 Sureshkumar P,Jones M,Cumming R,et al.A population based study of 2,856 school-age children with urinary incontinence[J].J Urol,2009,181(2):808-815.DOI:10.1016/j.juro.2008.10.044.
11 Fuentes M,Magalh?es J,Barroso U Jr.Diagnosis and management of bladder dysfunction in neurologically normal children[J].Front Pediatr,2019,7:298.DOI:10.3389/fped.2019.00298.
12 Stein R,Bogaert G,Dogan HS,et al.Eau/espu guidelines on the management of neurogenic bladder in children and adolescent part i diagnostics and conservative treatment[J].Neurourol Urodyn,2020,39(1):45-57.DOI:10.1002/nau.24211.
13 Phull H,Salkini M,Escobar C,et al.The role of angiotensin ii in stress urinary incontinence:A rat model[J].Neurourol Urodyn,2007,26(1):81-88,89.DOI:10.1002/nau.20339.
14 Cho ST,Park EY,Kim JC.Effect of angiotensin ii receptor antagonist telmisartan on detrusor overactivity in rats with bladder outlet obstruction[J].Urology,2012,80(5):1163.e1-e7.DOI:10.1016/j.urology.2012.05.002.
15 Lam DS,Dias LS,Moore KH,et al.Angiotensin ii in child urinary bladder:Functional and autoradiographic studies[J].BJU Int,2000,86(4):494-501.DOI:10.1046/j.1464-410x.2000.00771.x.
16 Weaver-Osterholtz D,Reams G,De Vergel CF,et al.The bladder angiotensin system in female rats:Response to infusions of angiotensin i and the angiotensin converting enzyme inhibitor enalaprilat[J].J Urol,2001,165(5):1735-1738.
17 Aikawa K,Sakai T,Ishibashi K,et al.Involvement of angiotensin ii type 1 receptor on pathological remodeling and dysfunction in obstructed bladder[J].Int J Urol,2012,19(5):457-464.DOI:10.1111/j.1442-2042.2012.02965.x.
18 Tanabe N,Ueno A,Tsujimoto G.Angiotensin ii receptors in the rat urinary bladder smooth muscle:Type 1 subtype receptors mediate contractile responses[J].J Urol,1993,150(3):1056-1059.DOI:10.1080/13813455.2018.1555669.
19 Mori K,Noguchi M,Tobu S,et al.Age-related changes in bladder function with altered angiotensin ii receptor mechanisms in rats[J].Neurourol Urodyn,2016,35(8):908-913.DOI:10.1002/nau.22849.
20 Comiter C,Phull HS.Angiotensin ii type 1 (at-1) receptor inhibition partially prevents the urodynamic and detrusor changes associated with bladder outlet obstruction:A mouse model[J].BJU Int,2012,109(12):1841-1846.DOI:10.1111/j.1464-410X.2011.10580.x.
21 Ito H,Taga M,Tsuchiyama K,et al.Ipss is lower in hypertensive patients treated with angiotensin-ii receptor blocker:Posthoc analyses of a lower urinary tract symptoms population[J].Neurourol Urodyn,2013,32(1):70-74.DOI:10.1002/nau.22267.
22 Elliott CS,Comiter CV.The effect of angiotensin inhibition on urinary incontinence:Data from the national health and nutrition examination survey (2001-2008)[J].Neurourol Urodyn,2014,33(8):1178-1181.DOI:10.1002/nau.22480.
23 Ramos-Filho AC,A Faria J,Calmasini FB,et al.The renin-angiotensin system plays a major role in voiding dysfunction of ovariectomized rats[J].Life Sci,2013,93(22):820-829.DOI:10.1016/j.lfs.2013.09.008.
24 Casanova JE.Incontinence after use of enalapril[J].J Urol,1990,143(6):1237-1238.DOI:10.1016/s0022-5347(17)40240-0.
25 Hadzhibozheva P,Tolekova A,Kalfin R,et al.Analysis of angiotensin ii-induced rat urinary bladder contractions in the presence of angiotensin ii receptors blockers[J].Arch Physiol Biochem,2021,127(1):1-5.DOI:10.1080/13813455.2018.1555669.
26 Kristek F,Malekova M,Ondrias K,et al.Blood pressure-independent hypotrophy of the heart,kidneys and conduit arteries after 7-nitroindazole administration to wistar rats from the prenatal period to adulthood[J].J Physiol Pharmacol,2013,64(1):35-39.
27 Bosnyak S,Jones ES,Christopoulos A,et al.Relative affinity of angiotensin peptides and novel ligands at at1 and at2 receptors[J].Clin Sci (Lond),2011,121(7):297-303.DOI:10.1042/CS20110036.
28 Fusco F,Creta M,De Nunzio C,et al.Progressive bladder remodeling due to bladder outlet obstruction:A systematic review of morphological and molecular evidences in humans[J].BMC Urology,2018,18(1):15.DOI:10.1186/s12894-018-0329-4.
29 Yamada S,Takeuchi C,Oyunzul L,et al.Bladder angiotensin-ii receptors:Characterization and alteration in bladder outlet obstruction[J].Eur Urol,2009,55(2):482-489.DOI:10.1016/j.eururo.2008.03.015.
30 Park JM,Borer JG,Freeman MR,et al.Stretch activates heparin-binding egf-like growth factor expression in bladder smooth muscle cells[J].Am J Physiol,1998,275(5):C1247-C1254.DOI:10.1152/ajpcell.1998.275.5.C1247.
31 Palmer LS,Lee C,Decker RS,et al.The effect of angiotensin converting enzyme inhibition and angiotensin ii receptor antagonism on obstructed rat bladder[J].J Urol,1997,158(3 Pt 2):1100-1104.DOI:10.1097/00005392-199709000-00105.
32 Persson K,Pandita RK,Waldeck K,et al.Angiotensin ii and bladder obstruction in the rat:Influence on hypertrophic growth and contractility[J].Am J Physiol,1996,271(5 Pt 2):R1186-R1192.DOI:10.1152/ajpregu.1996.271.5.R1186.
33 Bedecs K,Elbaz N,Sutren M,et al.Angiotensin ii type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of shp-1 tyrosine phosphatase[J].Biochem J,1997,325(Pt 2):449-454.DOI:10.1042/bj3250449.
34 Kaschina E,Lauer D,Schmerler P,et al.At2 receptors targeting cardiac protection post-myocardial infarction[J].Curr Hypertens Rep,2014,16(7):441.DOI:10.1007/s11906-014-0441-0.
35 Maejima Y,Okada H,Haraguchi G,et al.Telmisartan,a unique arb,improves left ventricular remodeling of infarcted heart by activating ppar gamma[J].Lab Invest,2011,91(6):932-944.DOI:10.1038/labinvest.2011.45.
36 Pereira RM,Dos Santos RA,Teixeira MM,et al.The renin-angiotensin system in a rat model of hepatic fibrosis:Evidence for a protective role of angiotensin-(1-7)[J].J Hepatol 2007,46(4):674-681.DOI:10.1016/j.jhep.2006.10.018.
37 Sim?es E Silva AC,Teixeira MM.ACE inhibition,ace2 and angiotensin-(1-7) axis in kidney and cardiac inflammation and fibrosis[J].Pharmacol Res,2016,107:154-162.DOI:z10.1016/j.phrs.2016.03.018.
38 Cao Y,Liu Y,Shang J,et al.Ang-(1-7) treatment attenuates lipopolysaccharide-induced early pulmonary fibrosis[J].Lab Invest,2019,99(12):1770-1783.DOI:10.1038/s41374-019-0289-7.
39 Sim?es E Silva AC,Silveira KD,Ferreira AJ,et al.Ace2,angiotensin-(1-7) and mas receptor axis in inflammation and fibrosis[J].Br J Pharmacol,2013,169(3):477-492.DOI:10.1111/bph.12159.
40 Grobe JL,Mecca AP,Lingis M,et al.Prevention of angiotensin ii-induced cardiac remodeling by angiotensin-(1-7)[J].Am J Physiol Heart Circ Physiol,2007,292(2):H736-H742.DOI:10.1152/ajpheart.00937.2006.
41 Tallant EA,Clark MA.Molecular mechanisms of inhibition of vascular growth by angiotensin-(1-7)[J].Hypertension,2003,42(4):574-579.DOI:10.1161/01.HYP.0000090322.55782.30.
42 Zhang F,Ren X,Zhao M,et al.Angiotensin-(1-7) abrogates angiotensin ii-induced proliferation,migration and inflammation in vsmcs through inactivation of ros-mediated pi3k/akt and mapk/erk signaling pathways[J].Sci Rep,2016,6:34621.DOI:10.1038/srep34621.
43 Martínez-Klimova E,Aparicio-Trejo OE,Tapia E,et al.Unilateral ureteral obstruction as a model to investigate fibrosis-attenuating treatments[J].Biomolecules,2019,9(4):141.DOI:10.3390/biom9040141.
44 Klahr S,Morrissey J.Obstructive nephropathy and renal fibrosis[J].Am J Physiol Renal Physiol,2002,283(5):F861-F875.DOI:10.1152/ajprenal.00362.2001.
45 Felsen D,Schulsinger D,Gross SS,et al.Renal hemodynamic and ureteral pressure changes in response to ureteral obstruction:The role of nitric oxide[J].J Urol,2003,169(1):373-376.DOI:10.1097/01.ju.0000039820.60560.74.
46 Hassanshahi J,Maleki M,Nematbakhsh M.Renin-angiotensin system and unilateral ureteral obstruction[J].Physiol Pharmacol,2018,21.
47 Esteban V,Lorenzo O,Rupérez M,et al.Angiotensin ii,via at1 and at2 receptors and nf-kappab pathway,regulates the inflammatory response in unilateral ureteral obstruction[J].J Am Soc Nephrol,2004,15(6):1514-1529.DOI:10.1097/01.asn.0000130564.75008.f5.
48 Burns WC,Velkoska E,Dean R,et al.Angiotensin ii mediates epithelial-to-mesenchymal transformation in tubular cells by ang 1-7/mas-1-dependent pathways[J].Am J Physiol Renal Physiol,2010,299(3):F585-F593.DOI:10.1152/ajprenal.00538.2009.
49 Bhaskaran M,Reddy K,Radhakrishanan N,et al.Angiotensin ii induces apoptosis in renal proximal tubular cells[J].Am J Physiol Renal Physiol,2003,284(5):F955-F965.DOI:10.1152/ajprenal.00246.2002.
50 Ito K,Chen J,El Chaar M,et al.Renal damage progresses despite improvement of renal function after relief of unilateral ureteral obstruction in adult rats[J].Am J Physiol Renal Physiol,2004,287(6):F1283-F1293.DOI:10.1152/ajprenal.00441.2003.
51 Topcu SO,Pedersen M,N?rregaard R,et al.Candesartan prevents long-term impairment of renal function in response to neonatal partial unilateral ureteral obstruction[J].Am J Physiol Renal Physiol,2007,292(2):F736-F748.DOI:10.1152/ajprenal.00441.2003.
52 Gheitasi I,Moosavi SM.Combination therapy with losartan and α-tocopherol in acute ureteral obstruction-induced renal excretory dysfunction and acidification defect[J].Iran J Med Sci,2014,39(4):357-366.
53 Zhong J,Guo D,Chen CB,et al.Prevention of angiotensin ii-mediated renal oxidative stress,inflammation,and fibrosis by angiotensin-converting enzyme 2[J].Hypertension,2011,57(2):314-322.DOI:10.1161/HYPERTENSIONAHA.110.164244.
54 Chow BS,Kocan M,Bosnyak S,et al.Relaxin requires the angiotensin ii type 2 receptor to abrogate renal interstitial fibrosis[J].Kidney Int,2014,86(1):75-85.DOI:10.1038/ki.2013.518.
55 Hassanshahi J,Nematbakhsh M.The role of mas receptor on renal hemodynamic responses to angiotensin 1-7 in both irreversible and reversible unilateral ureteral obstruction rats[J].Adv Biomed Res,2018,7:12.DOI:10.4103/abr.abr_176_17.
56 Kim CS,Kim IJ,Bae EH,et al.Angiotensin-(1-7) attenuates kidney injury due to obstructive nephropathy in rats[J].PLoS One,2015,10(11):e0142664.DOI:10.1371/journal.pone.0142664.
57 Zimmerman DL,Zimpelmann J,Xiao F,et al.The effect of angiotensin-(1-7) in mouse unilateral ureteral obstruction[J].Am J Pathol,2015,185(3):729-740.DOI:10.1016/j.ajpath.2014.11.013.
58 Chappel MC,Ferrario CM.Ace and ace2:Their role to balance the expression of angiotensin ii and angiotensin-(1-7)[J].Kidney Int,2006,70(1):8-10.DOI:10.1038/sj.ki.5000321.
59 Liu Z,Huang XR,Chen HY,et al.Loss of angiotensin-converting enzyme 2 enhances tgf-β/smad-mediated renal fibrosis and nf-κb-driven renal inflammation in a mouse model of obstructive nephropathy[J].Lab Invest,2012,92(5):650-661.DOI:10.1038/labinvest.2012.2.
60 Esteban V,Heringer-Walther S,Sterner-Kock A,et al.Angiotensin-(1-7) and the g protein-coupled receptor mas are key players in renal inflammation[J].PLoS One,2009,4(4):e5406.DOI:10.1371/journal.pone.0005406.
61 Verma A,Panda SS,Bajpai M.Role of endoscopic treatment of vesico-ureteric reflux in downgrading renin angiotensin system activation[J].J Pediatr Urol,2014,10(2):386-390.DOI:10.1016/j.jpurol.2013.10.015.
62 Mattoo TK.Medical management of vesicoureteral reflux-quiz within the article.Don’t overlook placebos[J].Pediatr Nephrol,2007,22(8):1113-1120.DOI:10.1007/s00467-007-0485-3.